Volume 29, Issue 3 pp. 664-669
Original Article
Free Access

Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease

Stephen H. Caldwell

Corresponding Author

Stephen H. Caldwell

Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA

Division of Gastroenterology and Hepatology, Box 145, University of Virginia Health Sciences Center, Charlottesville, VA 22908. fax: (804) 924-0491===Search for more papers by this author
David H. Oelsner

David H. Oelsner

Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA

Search for more papers by this author
Julia C. Iezzoni

Julia C. Iezzoni

Department of Pathology, University of Virginia, Charlottesville, VA

Search for more papers by this author
Elizabeth E. Hespenheide

Elizabeth E. Hespenheide

Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA

Search for more papers by this author
Emily H. Battle

Emily H. Battle

Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA

Search for more papers by this author
Carolyn J. Driscoll

Carolyn J. Driscoll

Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA

Search for more papers by this author
First published: 30 December 2003
Citations: 857

Abstract

We characterized 70 consecutive patients with cryptogenic cirrhosis to assess major risks for liver disease. Each patient was reevaluated for past alcohol exposure, scored by the International Autoimmune Hepatitis (IAH) score and assessed for viral hepatitis risks and risks for nonalcoholic steatohepatitis (NASH). The results were compared with 50 consecutive NASH patients, 39 nonalcoholic patients age 50 and over with cirrhosis from hepatitis C, and 33 consecutive patients with cirrhosis caused by primary biliary cirrhosis (PBC). Among the cryptogenic group, 49 (70%) were female, and the mean age was 63 ± 11 years. Although ascites and variceal bleeding were common, almost one half lacked major signs of complicated portal hypertension. A history of Type 2 diabetes mellitus and/or obesity was present in 51 (73%). Nineteen (27%) patients had a history of blood transfusions antedating the diagnosis of cirrhosis. No clinical or histological features distinguished this group from the other patients, and 14 (74%) of these had a history of obesity and/or diabetes. Nineteen of the remaining nontransfused patients had indeterminant IAH scores but were histologically and biochemically indistinguishable from the others. Twelve of these (63%) also had a history of obesity and/or diabetes. Both diabetes and obesity were significantly more common in the cryptogenic cirrhotic patients compared with the cirrhotic patients with PBC or hepatitis C. In contrast, the prevalence of obesity and diabetes was similar to the NASH patients who were, on average, a decade younger. Although there is some diversity that indicates more than one cause, our findings suggest that NASH plays an under-recognized role in many patients with cryptogenic cirrhosis, most of whom are older, type 2 diabetic and obese females.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.